- VSee Health (NASDAQ:VSEE) received approval from Nasdaq.
- The extension requires VSEE to file delayed Q1 and Q2 2025 Form 10-Q reports by October 15, 2025.
- The company must also demonstrate compliance with Nasdaq’s equity rule by December 1, 2025.
- Source: Press release